Diligence memo · auto-generated · as of July 2, 2026
Elevate Clinical Research, Inc.
Elevate Clinical Research, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Elevate Clinical Research, Inc. operates in Healthtech, based in AUSTIN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Elevate Clinical Research, Inc. has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2025-06-01.
Most recent recorded round closed around 2025-06-01.
Valuation (modeled)modeled
Provath models Elevate Clinical Research, Inc. at approximately $2.7M (range $627K–$7.0M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 3.52× the median modeled value of Pre-Seed Healthtech companies in 2025–2027 (43 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 13 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 29% of Healthtech peers (2138 compared).
Modeled value ranks above 17% of those peers.
Closest niche peers: Impulse Medical, Inc., HCSVS Mental Health Telemedicine Startup P.B.C., Freedom Health Management, LLC, Imagen Preferred Dental Support Services, LLC, Praos Health, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.